Article
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification.
Current cardiology reports - 12 Jan 2021
Stafford Fergus, Thomson Kate, Butters Alexandra, Ingles Jodie
Abstract excerpt
PURPOSE OF REVIEW: Our knowledge of the genetic basis and molecular pathogenesis of hypertrophic cardiomyopathy (HCM) continues to evolve. We describe the genetic basis of HCM, recent advances in genetic testing and the role of genetics in guiding risk stratification and management, both now and in the future. RECENT FINDINGS: While initially thought to be an exclusively Mendelian disease, we now know there are...
Topics
- Cardiomyopathy, Hypertrophic
- Genetic Testing
- Genotype
- Humans
- Mutation
- Risk Assessment
- Sarcomeres
